Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to Investigators Identify Glutathione as a Marker for Mitochondrial Disorders

    • Heterodimer Immunoassay Kit
    • Singulex
    • The Erenna® Interleuken-17A/F (IL-17A/F) heterodimer immunoassay kit is an addition to a suite of TH17 pathway bioassays which also includes IL-17A and IL-17F as well as several others. These biomarkers are members of the IL-17 signaling pathw
    • Tumor Marker Control
    • Randox Laboratories
    • The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
    • Mitochondrial Toxicity Assays
    • INDIGO Biosciences
    • A new series of assays called the MitoVir platform evaluate mitochondrial toxicity by examining inhibition of the ribonucleoside triphosphates that are substrates for the human mitochondrial RNA polymerase (POLRMT). The MitoVir platform is based on
    • DNA Reference Standard
    • Horizon Discovery
    • The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
    • Protein Biomarker Immunoassays
    • Olink Bioscience
    • Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
  • Page 1 of 1 (5 items) 1 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll